TABLE 2.
Patient‐derived cell cultures | Non neural cell cultures (fibroblasts/blood cells) | IPSCs derived 2D neural cell cultures | IPSCs derived 3D neural cell cultures | Direct reprogrammed neural cell cultures | Resected human brain tissue cultures |
---|---|---|---|---|---|
Basic characteristic | Represents pathophysiology of general cellular processes, and metabolism, suitable for genetic screening | Represents a broad range of neural cell types, providing a platform for disease modeling (synapses, electrical activity, neural proteins, neural networks, cell–cell interactions) | Models in vivo like conditions, allows complex interactions, stuctural changes, cell type composition, neurogenesis, cell migration, neural connectivity, electrical activity | Direct conversion to neural cells without going through the pluripotent state (synapses, electrical activity, neural proteins, basic properties of neural network, cell–cell interactions) | Reflects in vivo conditions, preserves cytoarchitecture, cell type composition, neural connectivity, electrical activity of epileptogenic neural tissue, suitable for genetic screening |
Primary cells or tissue sample | Non neural cells | Non neural cells | Non neural cells | Non neural cells | Brain tissue |
Presence of brain specific de novo somatic variants |
Limited (depends on primary cells) | Limited (depends on primary cells) | Limited (depends on primary cells) | Limited (depends on primary cells) | Yes (brainarea dependent) |
Invasiveness of cell or tissue collection | Non invasive (potentially invasive for obtaining skin fibroblasts) | Non invasive (potentially invasive for obtaining skin fibroblasts) | Non invasive (potentially invasive for obtaining skin fibroblasts) | Non invasive (potentially invasive for obtaining skin fibroblasts) | Invasive (brain surgery) |
Developmental stage | Patient's age | Early stages of development | Early stages of development | Patient's age | Patient's age |
Demands for cell system establishment | |||||
Procedure | Easy | Challenging (requires iPSC generation from non neural cells and 2D neural differentiation) | Challenging (requires iPSC generation from non neural cells and 3D neural differentation) | Moderate | Challenging (requires surgical resection of brain tissue; from a specific subgroup of patients) |
Time | Short (days–months) |
Long (usually shorter than 3D cultures; 1–3 years) Ref. [22] |
Long (1–3 years) Ref. [22] |
Moderate (1–5 months) |
Short (days–months) |
Financial cost | Low | High (influenced by reprogramming and differentiation procedures) | High (influenced by reprogramming and longer differentiation procedures) | Moderate (influenced by direct reprogramming procedures) | Low (excluding the financial cost of the surgery) |
Abbreviations: 2D, two dimensional; 3D, three dimensional; iPSCs, induced pluripotent stem cells.